DE69520681D1 - Nicht selbstinaktivierende retrovirale vektoren mit gezielter expression - Google Patents

Nicht selbstinaktivierende retrovirale vektoren mit gezielter expression

Info

Publication number
DE69520681D1
DE69520681D1 DE69520681T DE69520681T DE69520681D1 DE 69520681 D1 DE69520681 D1 DE 69520681D1 DE 69520681 T DE69520681 T DE 69520681T DE 69520681 T DE69520681 T DE 69520681T DE 69520681 D1 DE69520681 D1 DE 69520681D1
Authority
DE
Germany
Prior art keywords
region
self
retroviral vectors
targeted expression
inactivating retroviral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69520681T
Other languages
English (en)
Other versions
DE69520681T2 (de
Inventor
Henry Guenzburg
Michael Saller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helmholtz Zentrum Muenchen Deutsches Forschung De
Original Assignee
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH filed Critical Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Publication of DE69520681D1 publication Critical patent/DE69520681D1/de
Application granted granted Critical
Publication of DE69520681T2 publication Critical patent/DE69520681T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Ceramic Products (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Traffic Control Systems (AREA)
  • Navigation (AREA)
  • Road Signs Or Road Markings (AREA)
  • Molds, Cores, And Manufacturing Methods Thereof (AREA)
  • Optical Radar Systems And Details Thereof (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
DE69520681T 1994-09-02 1995-09-01 Nicht selbstinaktivierende retrovirale vektoren mit gezielter expression Expired - Lifetime DE69520681T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK101794 1994-09-02
PCT/EP1995/003445 WO1996007748A1 (en) 1994-09-02 1995-09-01 Non self-inactivating, expression targeted retroviral vectors

Publications (2)

Publication Number Publication Date
DE69520681D1 true DE69520681D1 (de) 2001-05-17
DE69520681T2 DE69520681T2 (de) 2001-11-29

Family

ID=8100062

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69520681T Expired - Lifetime DE69520681T2 (de) 1994-09-02 1995-09-01 Nicht selbstinaktivierende retrovirale vektoren mit gezielter expression

Country Status (21)

Country Link
US (1) US7531353B1 (de)
EP (1) EP0779929B1 (de)
JP (1) JP4037446B2 (de)
CN (1) CN1117156C (de)
AT (1) ATE200517T1 (de)
AU (1) AU688590B2 (de)
BR (1) BR9508664A (de)
CA (1) CA2198210C (de)
DE (1) DE69520681T2 (de)
DK (1) DK0779929T5 (de)
EE (1) EE03492B1 (de)
ES (1) ES2156945T3 (de)
FI (1) FI970892A (de)
HK (1) HK1001527A1 (de)
HU (1) HU221607B (de)
MX (1) MX9701544A (de)
NO (1) NO317731B1 (de)
NZ (1) NZ292897A (de)
PL (1) PL184375B1 (de)
RU (1) RU2199585C2 (de)
WO (1) WO1996007748A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0779929B1 (de) 1994-09-02 2001-04-11 Gsf-Forschungszentrum Für Umwelt Und Gesundheit, Gmbh Nicht selbstinaktivierende retrovirale vektoren mit gezielter expression
WO1996028563A1 (en) * 1995-03-09 1996-09-19 Bavarian Nordic Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy
JP4119952B2 (ja) 1995-06-27 2008-07-16 バヴァリアン・ノルディック・アクティーゼルスカブ ウイルス粒子産生カプセル化細胞
US7074398B1 (en) 1995-10-13 2006-07-11 Gsf-Forschungszentrum Fuer Umwelt Und Gesundheit Gmbh Retroviral vectors carrying senescent cell derived inhibitors 1 (SDI-1)or antisense SDI-1 nucleotide sequences
EP0859854B1 (de) * 1995-10-13 2002-05-02 Austrian Nordic Biotherapeutics AG Retrovirale vektoren die inhibitoren der dna synthese (sdi-1) oder antisense sdi-1 nukleotid sequenzen tragen
PL188323B1 (pl) 1996-03-27 2005-01-31 Bavarian Nordic As Kapsuła zawierająca komórki i jej zastosowanie oraz kompozycja i środek farmaceutyczny
US6540995B1 (en) 1996-03-27 2003-04-01 Bavarian Nordic Research Institute Gmbh Encapsulated cells producing cytochrome P450
WO1999032646A1 (en) * 1997-12-22 1999-07-01 Oxford Biomedica (Uk) Limited Equine infectious anaemia virus (eiav) based
WO1998032869A1 (en) * 1997-01-29 1998-07-30 Neurosearch A/S Expression vectors and methods for in vivo expression of therapeutic polypeptides
DE69920659T2 (de) 1998-01-06 2006-03-09 Institut für Virologie Teilrechtsfähiges Institut an der Veterinärmedizinischen Universität Wien Rekonstituierender retroviraler vektor (recon vektor) für gezielte genexpression
FR2778670B1 (fr) * 1998-05-18 2002-12-13 Rhone Poulenc Rorer Sa Methodes et compositions pour la production de particules virales
DE19910650A1 (de) * 1999-03-10 2000-09-21 Gsf Forschungszentrum Umwelt Auf HERV-LTR-Sequenzen basierende retrovirale Expressionsvektoren
AU4559800A (en) * 1999-04-29 2000-11-17 Aarhus Universitet Expression of heterologous genes from an ires translational cassette in retroviral vectors
WO2002064805A2 (en) * 2001-02-09 2002-08-22 Institut für Virologie Teilrechtsfähiges Institut an der Veterinärmedizinischen Universität Wien Replication competent non-mammalian retroviral vectors
DE102009021592A1 (de) * 2009-05-15 2010-11-18 Medizinische Hochschule Hannover ASLV-Vektorsystem

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68927089T2 (de) 1988-05-17 1997-04-03 Sloan Kettering Inst Cancer Retroviraler vektor
GB8919607D0 (en) * 1989-08-30 1989-10-11 Wellcome Found Novel entities for cancer therapy
WO1994029437A1 (en) * 1993-06-07 1994-12-22 University Of Medicine & Dentistry Of New Jersey Highly-efficient, self-inactivating, recombination-free, u3-free retroviral vectors
EP0779929B1 (de) 1994-09-02 2001-04-11 Gsf-Forschungszentrum Für Umwelt Und Gesundheit, Gmbh Nicht selbstinaktivierende retrovirale vektoren mit gezielter expression
DK0817859T3 (da) * 1995-03-09 2002-04-29 Austrian Nordic Biotherapeutic Rekombinante DNA vektorer til Genterapi
WO1996028563A1 (en) * 1995-03-09 1996-09-19 Bavarian Nordic Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy
US6117681A (en) * 1995-03-29 2000-09-12 Bavarian Nordic Research Inst. A/S Pseudotyped retroviral particles
GB9510272D0 (en) 1995-05-22 1995-07-19 Isis Innovation Retroviral vectors
US7074398B1 (en) * 1995-10-13 2006-07-11 Gsf-Forschungszentrum Fuer Umwelt Und Gesundheit Gmbh Retroviral vectors carrying senescent cell derived inhibitors 1 (SDI-1)or antisense SDI-1 nucleotide sequences

Also Published As

Publication number Publication date
WO1996007748A1 (en) 1996-03-14
HU221607B (hu) 2002-11-28
PL319033A1 (en) 1997-07-21
BR9508664A (pt) 1998-01-06
AU688590B2 (en) 1998-03-12
CN1117156C (zh) 2003-08-06
HUT76974A (hu) 1998-01-28
NZ292897A (en) 1998-08-26
NO970902L (no) 1997-04-24
FI970892A0 (fi) 1997-02-28
ES2156945T3 (es) 2001-08-01
DK0779929T5 (da) 2001-08-13
EE9700040A (et) 1997-08-15
FI970892A (fi) 1997-02-28
CA2198210A1 (en) 1996-03-14
AU3520195A (en) 1996-03-27
MX9701544A (es) 1998-03-31
RU2199585C2 (ru) 2003-02-27
EP0779929B1 (de) 2001-04-11
NO970902D0 (no) 1997-02-27
JP4037446B2 (ja) 2008-01-23
CN1159210A (zh) 1997-09-10
HK1001527A1 (en) 1998-06-26
CA2198210C (en) 2006-07-11
US7531353B1 (en) 2009-05-12
DK0779929T3 (da) 2001-05-07
EE03492B1 (et) 2001-08-15
EP0779929A1 (de) 1997-06-25
ATE200517T1 (de) 2001-04-15
DE69520681T2 (de) 2001-11-29
PL184375B1 (pl) 2002-10-31
JPH10507628A (ja) 1998-07-28
NO317731B1 (no) 2004-12-13

Similar Documents

Publication Publication Date Title
ATE200517T1 (de) Nicht selbstinaktivierende retrovirale vektoren mit gezielter expression
WO1998039463A3 (en) Lentivirus based vector and vector system
EE04378B1 (xx) LAG-3 pleissimisteisendid
EP0624680A4 (de) Behandlungsmittel für faserprodukte, verfahren zum behandeln von faserprodukten und die dadurch behandelten faserprodukte.
ATE199704T1 (de) Herstellung von pentafluoroethane
DE60237791D1 (de) Zytokinproteinfamilie
CA2267945A1 (en) Anticonvulsant derivatives useful in treating neuropathic pain
DE59109072D1 (de) Klonierung der N-Methylhydantoinase
ID20153A (id) Proses polimerisasi etilena dengan adanya suatu katalis kromium oksida
DE69321235D1 (de) Promoter vom k. lactis pyruvat-decarboxylase gen und anwendung davon
DK0812866T3 (da) Lagerstabil fugtighedshærdende klæbestofmasse
IE841943L (en) 5-SUBSTITUTED £1,2,4| TRIAZOLO £1,5-c| PYRIMIDIN -2- AMINES
DE3563752D1 (en) Compounds having hypolipemizing activity
DE59109126D1 (de) N-Carbamoylsarcosin-Amidohydrolase, kloniert
UA20042A (uk) Біс-n,n-диметил-n-(2-гідрокси-3-бутоксипропіл) аміhо-ізо-фталімід як латеhтhий каталізатор отвердіhhя епоксидhих композицій
UA20041A (uk) Біс-n,n-диметил-n-(2-гідрокси-3-бутоксипропіл) аміhоадипоілімід як латеhтhий каталізатор отвердіhhя епоксидhих композицій
DE69729098D1 (de) Fluorierung von ketoamiden

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: GSF - FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNG, DE